KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) EBITDA (2016 - 2025)

Historic EBITDA for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $853.0 million.

  • Tenet Healthcare's EBITDA rose 389.77% to $853.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 billion, marking a year-over-year decrease of 4110.14%. This contributed to the annual value of $4.2 billion for FY2025, which is 3630.72% down from last year.
  • As of Q4 2025, Tenet Healthcare's EBITDA stood at $853.0 million, which was up 389.77% from $889.0 million recorded in Q3 2025.
  • Over the past 5 years, Tenet Healthcare's EBITDA peaked at $3.3 billion during Q1 2024, and registered a low of $520.0 million during Q1 2021.
  • Its 5-year average for EBITDA is $858.9 million, with a median of $743.0 million in 2021.
  • Per our database at Business Quant, Tenet Healthcare's EBITDA skyrocketed by 44477.61% in 2024 and then plummeted by 7129.38% in 2025.
  • Quarter analysis of 5 years shows Tenet Healthcare's EBITDA stood at $751.0 million in 2021, then dropped by 28.63% to $536.0 million in 2022, then surged by 37.13% to $735.0 million in 2023, then rose by 11.7% to $821.0 million in 2024, then grew by 3.9% to $853.0 million in 2025.
  • Its EBITDA stands at $853.0 million for Q4 2025, versus $889.0 million for Q3 2025 and $823.0 million for Q2 2025.